How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
News headlines Recursion Pharmaceuticals reported mixed Q2 2026 results, showing a $7.67 million revenue decline from last year. The company announced significant clinical advancements and strategic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results